4/24
06:19 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 23 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 23 Filed by: Tanimoto Sarina
4/24
06:18 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 23 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 23 Filed by: Lowenthal Richard E
4/22
07:23 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 19 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 19 Filed by: Tanimoto Sarina
4/22
07:22 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 19 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 19 Filed by: Lowenthal Richard E
4/17
06:43 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 16 Filed by: Tanimoto Sarina
Medium
Report
Form 4 ARS Pharmaceuticals, For: Apr 16 Filed by: Tanimoto Sarina
4/17
06:41 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 16 Filed by: Lowenthal Richard E
Medium
Report
Form 4 ARS Pharmaceuticals, For: Apr 16 Filed by: Lowenthal Richard E
4/10
05:40 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 09 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 09 Filed by: Tanimoto Sarina
4/10
05:37 pm
spry
Form 4 ARS Pharmaceuticals, For: Apr 09 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Apr 09 Filed by: Lowenthal Richard E
3/29
04:14 pm
spry
Form SC 13D/A ARS Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SC 13D/A ARS Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
3/27
07:38 pm
spry
Form 4 ARS Pharmaceuticals, For: Mar 25 Filed by: Shah Rajeev M.
Low
Report
Form 4 ARS Pharmaceuticals, For: Mar 25 Filed by: Shah Rajeev M.
3/26
06:49 pm
spry
Form 4 ARS Pharmaceuticals, For: Mar 22 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Mar 22 Filed by: Lowenthal Richard E
3/26
06:48 pm
spry
Form 4 ARS Pharmaceuticals, For: Mar 22 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Mar 22 Filed by: Tanimoto Sarina
3/21
09:52 pm
spry
Form 4 ARS Pharmaceuticals, For: Mar 19 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Mar 19 Filed by: Lowenthal Richard E
3/21
09:51 pm
spry
Form 4 ARS Pharmaceuticals, For: Mar 19 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Mar 19 Filed by: Tanimoto Sarina
3/21
05:11 pm
spry
Form S-8 ARS Pharmaceuticals,
Medium
Report
Form S-8 ARS Pharmaceuticals,
3/21
04:15 pm
spry
Form 10-K ARS Pharmaceuticals, For: Dec 31
Low
Report
Form 10-K ARS Pharmaceuticals, For: Dec 31
3/21
04:07 pm
spry
Form 8-K ARS Pharmaceuticals, For: Mar 21
Low
Report
Form 8-K ARS Pharmaceuticals, For: Mar 21
3/15
07:55 pm
spry
Form 4 ARS Pharmaceuticals, For: Mar 13 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Mar 13 Filed by: Lowenthal Richard E
3/15
07:52 pm
spry
Form 4 ARS Pharmaceuticals, For: Mar 13 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Mar 13 Filed by: Tanimoto Sarina
3/7
12:58 pm
spry
Form 8-K ARS Pharmaceuticals, For: Mar 07
Low
Report
Form 8-K ARS Pharmaceuticals, For: Mar 07
3/1
08:22 pm
spry
Form 4 ARS Pharmaceuticals, For: Feb 29 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Feb 29 Filed by: Tanimoto Sarina
3/1
08:18 pm
spry
Form 4 ARS Pharmaceuticals, For: Feb 29 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Feb 29 Filed by: Lowenthal Richard E
2/28
09:11 pm
spry
Form 4 ARS Pharmaceuticals, For: Feb 26 Filed by: Tanimoto Sarina
Medium
Report
Form 4 ARS Pharmaceuticals, For: Feb 26 Filed by: Tanimoto Sarina
2/28
09:06 pm
spry
Form 4 ARS Pharmaceuticals, For: Feb 26 Filed by: Lowenthal Richard E
Medium
Report
Form 4 ARS Pharmaceuticals, For: Feb 26 Filed by: Lowenthal Richard E
2/26
12:09 pm
spry
Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina
Low
Report
Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina